Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06756373

Mangement of Pulmonary Emboli

Adherence to International Guidelines Directed Risk Stratification and Management of Acute Pulmonary Embolism, an Egyptian Experience

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

To assess to which extent we are adherent to ESC guidelines 2019 in management of patients presented with acute pulmonary embolism

Detailed description

Pulmonary embolism (PE) is the third most frequent cardiovascular disease and is associated with a high mortality burden PE is defined as the obstruction of a pulmonary artery, mostly resulting from the dislodgement of thrombotic material from the lower limbs. It has a wide variety of presentations, ranging from an asymptomatic incidental finding to circulatory collapse and sudden death Pulmonary embolism response teams (PERTs) have emerged as a multidisciplinary team for managing acute pulmonary embolism, with a rapid activation process for multimodality assessment, risk stratification and best management especially for complex challenge cases. PERTs help in improving time to PE diagnosis; shorter time to initiation of anticoagulation reducing hospital length of stay, increasing use of advanced therapies as catheter directed therapies without an increase in bleeding complications with decreasing mortality

Conditions

Timeline

Start date
2025-01-20
Primary completion
2026-12-17
Completion
2027-12-17
First posted
2025-01-03
Last updated
2025-01-03

Source: ClinicalTrials.gov record NCT06756373. Inclusion in this directory is not an endorsement.

Mangement of Pulmonary Emboli (NCT06756373) · Clinical Trials Directory